The Radiation Oncology Registry and Biosample Repository

Recruiting

• Conditions: Neoplasia

• Registration Number: NCT01577251
• Lead Sponsor: Abramson Cancer Center at Penn Medicine

Brief Summary

The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-06
• Study First Submitted: 2012-04-12
• Study First Submitted QC: 2012-04-12
• Study First Posted: 2012-04-13
• Status Verified: 2025-02
• Last Update Submitted: 2025-02-25
• Last Update Posted: 2025-02-27
• Primary Completion: 2030-12
• Study Completion: 2030-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 8000

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Health Assessments	10 years

Trial Locations

Locations (4)

Virtua Samson Cancer Center; 🇺🇸 Moorestown, New Jersey, United States

Virtua Health & Wellness Center; 🇺🇸 Voorhees, New Jersey, United States

Lancaster General Hospital; 🇺🇸 Lancaster, Pennsylvania, United States

University of Pennsylvania; 🇺🇸 Philadelphia, Pennsylvania, United States